|
Principal Investigator/Program
Director (Last, First, Middle): |
Goldstein,
David, Stanley |
|||
|
|
||||
BIOGRAPHICAL SKETCH
Provide the following
information for the key personnel and other significant contributors in the
order listed on Form Page 2. |
||||
|
|
||||
|
NAME Goldstein, David Stanley |
POSITION TITLE Chief, Clinical
Neurocardiology Section CNP, DIR, NINDS, NIH |
|||
|
eRA COMMONS USER NAME |
||||
|
EDUCATION/TRAINING (Begin
with baccalaureate or other initial professional education, such as nursing,
and include postdoctoral training.) |
||||
|
INSTITUTION AND LOCATION |
DEGREE (if applicable) |
YEAR(s) |
FIELD OF STUDY |
|
|
Yale
College |
B.A. |
1970 |
Psychology |
|
|
Johns
Hopkins University |
M.D., Ph.D. |
1976 |
Behavioral
Science |
|
|
University of Washington |
|
1978 |
Int. Med. Residency |
|
Positions and
Employment
1978-1982 Clinical Associate, NHLBI, Bethesda, MD
1982-1983 Medical Staff Fellow, NHLBI, Bethesda, MD
1983-1990 Senior Investigator, NHLBI, Bethesda, MD
1983-date Attending Physician, Clinical Center, NIH, Bethesda, MD,;
1990-date Senior Investigator, NINDS, Bethesda, MD
1992-1999 Chief, Clinical Neurochemistry Section, Clinical Neuroscience
Branch, NINDS, Bethesda, MD
1999-date Chief, Clinical Neurocardiology Section, NINDS, Bethesda, MD
Other Experience and Professional Memberships (Partial
Listing)
1986-date Fellow, American College of Physicians
1989-date Clinical Assoc. Professor of Medicine
(Cardiology), Georgetown University School of Medicine, Washington, DC
1996-date Fellow, American Heart Association
1997-date Member, Neural Control and Autonomic Regulation Section,
American Physiological Society
1999-date Founding Member, Association for Patient Oriented Research
1999-date Visiting Professor of Medicine, The Johns
Hopkins School of Medicine, Baltimore, MD
2000-date Member, Board of Directors, National Dysautonomic Research
Foundation
2000-date Member, Autonomic Nervous System Section, American Academy of
Neurology
2002-date Board of Governors, American Autonomic Society
2004-date IRB, NINDS
2004-date Visiting Professor of Medicine, Tel Aviv University-Sackler
Faculty of Medicine, Israel
2005-date Executive Board, Association for Patient Oriented Research
Honors (Partial Listing)
1970 Angier
Prize for Research in Psychology, Yale College
1994 Willem
Laufberger Medal, Czech Academy of Sciences, Czech Republic
1994, 2000 NIH Merit Award
2002 Presidential Executive
Director’s Award, National Dysautonomic Research Foundation
2004 NIH
Distinguished Clinical Teacher Award
2005 John
L. Decker Memorial Lecturer, NIH
Publications 333 original
research articles in peer-reviewed journals, 98 book chapters/reviews, 6 books
Bibliography
(Peer-reviewed original research articles, 2000-date, first-authored only due
to space limits):
Wong M-L,
Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P, Karp B, McCutcheon IA, Goldstein DS, Veldhuis JD, Chrousos GP,
Oldfield EH, McCann SM, Gold PW. Pronounced and sustained central
hypernoradrenergic function in major depression with melancholic features:
Relation to hypercotisolism and corticotropin-releasing hormone. PNAS
2000;97:325-330.
Jeong, K-H Jacobson L, Pacak K, Widmaier EP, Goldstein DS, Majzoub JA. Impaired basal and restraint-induced
epinephrine secretion in corticotropin-release hormone-deficient mice.
Endocrinology 2000;141:1142-1150.
Li S-T,
Tack C, Fananapazir L, Goldstein DS.
Myocardial perfusion and sympathetic innervation in patients with hypertrophic
cardiomyopathy. J Am Coll Cardiol 2000;35:1867-1873.
Goldstein DS, Tack C, Li S-T. Sympathetic innervation and function in reflex
sympathetic dystrophy. Ann Neurol 2000;48:49-59.
Frank SM,
Raja SN, Bulcao C, Goldstein DS.
Age-related thermoregulatory differences during core cooling in humans. Am J
Physiol 2000;279:R349-R354.
Goldstein DS, Holmes C, Li S-T, Bruce S, Metman LV, Cannon
RO III. Cardiac sympathetic denervation in Parkinson disease. Ann Intern Med
2000;133:338-347.
Pacak K, Linehan WM, Eisenhofer G, Walther MM, Goldstein DS. Recent advances in
genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann
Intern Med 2001;134:315-329.
Pacak
K, Fojo T, Goldstein DS, Eisenhofer
G, Walther MM, Linehan WM, Bachenheimer L, Abraham J, Wood BJ. Radiofrequency
ablation: A novel approach for treatment of metastatic pheochromocytoma. J Nat
Cancer Inst 2001;93:648-649.
Eisenhofer
G, Walther MM, Huynh T-T, Li S-T, Bornstein SR, Vortmeyer A, Mannelli M, Goldstein DS, Linehan WM, Lenders JWM,
Pacak K. Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine
neoplasia type 2 display distinct biochemical and clinical phenotypes. J Clin
Endocrinol Metab 2001;86:1999-2008.
Pacak
K, Goldstein DS, Doppman JL, Shulkin
BL, Udelsman R, Eisenhofer G. A “pheo” lurks: Novel approaches for localizing
occult pheochromocytoma. J Clin Endocrinol Metab 2001;86: 3641-3646.
Li
XX, Bek M, Asico LD, Yang Z, Grandy DK, Goldstein
DS, Rubinstein M, Eisner GM, Jose PA. Adrenergic and endothelin b
receptor-dependent hypertension in dopamine receptor type-2 knockout mice.
Hypertension 2001;38:303-308.
Goldstein DS, Li S-T, Kopin
IJ. Sympathetic neurocirculatory failure in Parkinson disease: Evidence for an
etiologic role of a-synuclein. Ann Intern Med 2001;135:1010-1011.
Pacak
K, Eisenhofer G, Li S-T, Goldstein DS.
6-[18F]Fluorodopamine positron emission
tomographic (PET) scanning for diagnostic localization of pheochromocytoma.
Hypertension 2001;38:6-8.
Goldstein DS, Katzper M,
Linares O, Kopin IJ. Kinetic model for the fate of the sympathoneural imaging
agent 6-[18F]fluorodopamine in the human heart: A novel means to
assess cardiac sympathetic neuronal function. Naunyn-Schmiedeberg’s Arch of
Pharmacol 2002;365:38-49.
Frank
SM, Goldstein DS. Threshold for
adrenomedullary activation and increased cardiac work during mild core
hypothermia in awake humans. Clin Sci 2002;102:119-125.
Lenders
JWM, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS, Eisenhofer G. Biochemical
diagnosis of pheochromocytoma: which test is best? JAMA 2002;287:1427-1434.
Goldstein DS, Holmes C,
Dendi R, Bruce S, Li S-T. Orthostatic hypotension from sympathetic denervation
in Parkinson’s disease. Neurology 2002;58:1247-1255.
Dendi
R, Goldstein DS. Meta-analysis of
nonselective versus beta-1 adrenoceptor-selective blockade in prevention of
tilt-induced neurocardiogenic syncope. Am J Cardiol 2002;89:1319-1321.
Patel
JN, Coppack SW, Goldstein DS, Miles
JM, Eisenhofer G. Norepinephrine spillover from human adipose tissue before and
after a 72-hour fast. J Clin Endocrinol Metab 2002;87:3373-3377.
Elman
I, Goldstein DS, Green AI,
Eisenhofer G, Folio CJ, Pickar D, Breier A. Effects of resperidone on the
peripheral noradrenergic system in patients with schizophrenia: A comparison
with clozapine and placebo. Neuropsychopharmacology 2002;27:293-300.
Jordan
J, Lipp A, Tank J, Schroder C, Stoffels M, Franke G, Diedrich A, Arnold
G, Goldstein DS, Sharma AM, Luft FC.
Catechol-O-methyl-transferase and blood pressure in humans. Circulation
2002;106:460-465.
Li
S-T, Dendi R, Holmes C, Goldstein DS.
Progressive loss of cardiac sympathetic innervation in Parkinson’s disease. Ann
Neurol 2002;52:220-223.
Pacak
K, Tjurmina O, Palkovits M, Goldstein DS,
Koch CA, Hoff T, Chrousos GP. Chronic hypercortisolemia inhibits dopamine
synthesis and turnover in the nucleus accumbens: An in vivo microdialysis
study. Neuroendocrinology
2002;76:148-157.
Goldstein DS, Holmes C,
Dendi R, Li S-T, Brentzel S, Vernino S. Pandysautonomia associated
with impaired ganglionic neurotransmission and a neuronal nicotinic receptor
antibody. Clin Auton Res 2002;12:281-285.
Goldstein DS, Holmes C, Frank
SM, Cannon RO III. Cardiac sympathetic innervation and function in chronic
orthostatic intolerance syndromes. Circulation 2002;106:2358-2369.
Goldstein DS, Robertson D,
Esler M, Straus SE. Dysautonomias: Clinical disorders of the autonomic nervous
system. Ann Intern Med 2002;137:753-763.
Tack
C, Goldstein DS. Local sympathetic
denervation in patients with painful diabetic neuropathy. Diabetes
2002;51:3545-3553.
Tjurmina
OA, Armando I, Saavedra JM, Goldstein DS,
Murphy DL. Exaggerated adrenomedullary response to immobilization in mice with
targeted disruption of the serotonin transporter gene. Endocrinology
2002;143:4520-4526.
Sharabi
Y, Li S-T, Dendi R, Holmes C, Goldstein
DS. Neurotransmitter specificity of sympathetic denervation in Parkinson’s
disease. Neurology 2003;60:1036-1039.
Goldstein DS, Holmes C, Frank
SM, Naqibuddin M, Dendi R, Snader S, Calkins H. Sympathoadrenal imbalance
before neurocardiogenic syncope. Am J Cardiol 2003;91:53-58.
Sun
M, Zhang G-r, Kong L, Holmes C, Wang X, Goldstein
DS, Geller AI. Correction of a rat model of Parkinson’s disease by
coexpression of tyrosine hydroxylase and aromatic amino acid decarboxylase from
a helper virus-free HSV-1 vector. Hum Gene Ther 2003;14:415-424.
Goldstein DS, Holmes C,
Sharabi Y, Brentzel S, Eisenhofer G. Plasma levels of catechols and
metanephrines in neurogenic orthostatic hypotension. Neurology
2003;60:1327-1332.
Goldstein DS, Holmes C,
Sharabi Y, Eisenhofer G. Cerebrospinal fluid levels of catechols in neurogenic
orthostatic hypotension. Clin Sci 2003;104:649-654.
Eisenhofer
G, Goldstein DS, Walther MM, Lenders
JWM, Friberg P, Keiser HR, Pacak K. Biochemical diagnosis of pheochromocytoma:
How to distinguish true- from false-positive test results. J Clin Endocrinol
Metab 2003;88:2656-2666.
Sharabi
Y, Dendi R, Holmes C, Goldstein DS.
Baroreflex failure as a late sequela of neck irradiation. Hypertension
2003;42:110-116.
Goldstein DS, Pechnik S,
Holmes C, Eldadah B, Sharabi Y. Association between supine hypertension and
orthostatic hypotension in autonomic failure. Hypertension 2003:42:136-142.
Kaufmann H, Saadia D, Voustianiouk A, Goldstein DS, Holmes C, Yahr MD, Nardin
R, Freeman R. Norepinephrine precursor therapy in neurogenic orthostatic
hypotension. Circulation 2003;108:724-728.
Goldstein DS, Li S-T, Holmes
C, Bankiewicz K. Sympathetic innervation in the MPTP primate model of
Parkinsons’s disease. J Pharmacol Exp Ther 2003;306:855-860.
Li
S-T, Holmes C, Kopin IJ, Goldstein DS.
Aging-related changes in cardiac sympathetic function in humans, assessed by
6-[18F]fluorodopamine positron emission tomographic scanning. J Nucl Med
2003;44:1599-1603.
Goldstein DS, Holmes C.
Vasodilation during systemic tyramine infusion. Circulation 2004 109:E17-E18.
Singleton
A, Gwinn-Hardy K, Sharabi Y, Li S-T, Holmes C, Dendi R, Hardy J, Singleton A,
Crawley A, Goldstein DS. Association
between cardiac sympathetic denervation and parkinsonism caused by a-synuclein
gene triplication. Brain 2004;127:768-772.
Eldadah
B, Pacak K, Holmes C. Sharabi Y, Kopin IJ, Eisenhofer G, Goldstein DS. Cardiac
uptake-1 inhibition by high circulating norepinephrine concentrations in
patients with pheochromocytoma. Hypertension 2004;43:1227-1232.
Sharabi
Y, Zimlichman R, Mansouri R, Chun J, Goldstein
DS. Does acetylcholinesterase inhibition affect catecholamine secretion by
adrenomedullary cells? Isr Med Assoc J. 2004;6:396-369.
Goldstein DS, Pechnik S,
Moak J, Eldadah B. Painful sweating. Neurology 2004;63:1471-1475.
Schroeder
C, Tank J, Goldstein DS, Stoeter M,
Haertter S, Luft FC, Jordan J. Influence of St. John’s wort on catecholamine
turnover and cardiovascular regulation in humans. Clin Pharmacol Ther
2004;76:480-489.
Elman
I, Rott D, Green AI, Langleben DD, Lukas SE, Goldstein DS, Breier A. Effects of pharmacological doses of
2-deoxyglucose on plasma catecholamines and glucose levels in patients with
schizophrenia. Psychopharmacology 2004;176:369-375.
Eisenhofer
G, Huynh T-T, Pacak K, Brouwers FM, Walther MM, Linehan WM, Munson PJ, Mannelli
M, Goldstein DS, Elkahloun AG.
Distinct gene expression profiles in norepinephrine and epinephrine producing
hereditary and sporadic pheochromocytoma hypoxia-driven angiogenic pathways in
von Hippel-Lindau syndrome.
Endocrine-Related Cancer 2004;11:897-911.
Goldstein DS, Holmes C,
Kaufmann H, Freeman R. Clinical pharmacokinetics of the norepinephrine
precursor L-threo-DOPS in primary chronic autonomic failure. Clin Auton Res
2004;14:363-368.
Goldstein DS, Eldadah
B, Holmes C, Pechnik S, Moak J, Sharabi Y. Neurocirculatory abnormalities in
chronic orthostatic intolerance. Circulation 2005;111:839-845.
Eisenhofer
G, Lenders JWM, Goldstein DS,
Mannelli M, Csako G, Walther MM, Brouwers, Pacak K. Pheochromocytoma
catecholamine phenotypes and prediction of tumor size and location using plasma
free metanephrines. Clin Chem 2005;51:735-744.
Gold
PW, Wong ML, Goldstein DS, Gold HK,
Ronsaville DS, Esler M, Alesci S, Masood A, Licinio J, Geracioti TD Jr, Perini
G, Debellis MD, Holmes C, Vgontzas AN, Charney DS, Chrousos GP, McCann SM,
Kling MA. Cardiac implications of increased arterial entry and reversible 24-h
central and peripheral norepinephrine levels in melancholia. PNAS
2005;102:8303-8308.
Moak
J, Eldadah B, Holmes C, Pechnik S, Goldstein
DS. Partial cardiac sympathetic denervation after bilateral thoracic
sympathectomy in humans. Heart Rhythm 2005;2:602-609.
Eisenhofer
G, Goldstein DS, Sullivan P, Csako
G, Brouwers F, Lai EW, Adams KT, Pacak K. Biochemical and clinical
manifestations of dopamine-producing paragangliomas: utility of plasma
methoxytyramine. J Clin Endcrinol Metab 2005;90:2068-2075.
Holmes
C, Moak J, Eldadah B, Zimmerly E, Sharabi Y,
Goldstein DS. Dopamine contamination
of infused tyramine. Clin Chem 2005;51:1733-1735.
Goldstein DS.
Orthostatic hypotension as an early finding in Parkinson disease. Clin Auton
Res (in press).
Gold
PW, Wong ML, Goldstein DS, Gold HK,
Ronsaville DS, Esler M, Alesci S, Masood A, Licinio J, Geracioti TD Jr, Perini
GI, Debellis MD, Vgontzas AN, Charney DS, Chrousos GP, McCann SM, Kling MA.
Melancholic depressed patients have sympathetic hyperactivity that is reversed
by electroconvulsive therapy. PNAS (in press).
Bibliography
(Chapters or reviews, 2000-date, partial listing due to space limits):
Goldstein DS. Sympathetic nervous system. In Fink G (Ed.) Encyclopedia
of Stress. New York: Academic Press, 2000, pp. 558-565.
Goldstein DS, Pacak K. Catecholamines in the brain and responses to
environmental challenges. In McEwen BS (Ed.) Handbook of Physiology. Coping
with the Environment. New York: Oxford Univ. Press, 2000, pp. 45-60.
Goldstein DS, Eisenhofer G. Sympathetic nervous system physiology and
pathophysiology in coping with the environment. In McEwen BS (Ed.) Handbook of
Physiology. Coping with the Environment. New York: Oxford Univ. Press, 2000,
pp. 21-43.
Eisenhofer G, Pacak K, Goldstein
DS. 123I-MIBG scintigraphy of catecholamine systems: Impediments
to applications in clinical medicine. Eur J Nucl Med 2000;27:611-612.
Goldstein DS. Physiology of the adrenal medulla and the sympathetic
nervous system. In Becker KL (Ed.) Principles and Practice of Endocrinology and
Metabolism. New York: Lippincott, 2001, pp. 817-826.
Goldstein DS. New clinical techniques to assess cardiac sympathetic
innervation and function in dysautonomias. In Orthostatic Intolerance, Neurally
Mediated Syncope, and Related Disorders. CME Monograph. San Antonio, TX: The
Dannemiller Memorial Educational Foundation, 2001, pp. 5-7.
Goldstein DS. Cardiac sympathetic neuroimaging to distinguish multiple
system atrophy from Parkinson disease. Clin Auton Res 2001;11:341-342.
Goldstein DS. Adrenaline and Noradrenaline. Encyclopedia of Life
Sciences. London: Macmillan Reference Limited, 2001, pp. 1-8.
Goldstein DS, Holmes CS, Frank SM. Stressor-specific activation of catecholamine
systems in humans. In Nagatsu T, Nabashima T, Goldstein DS (Eds.) Catecholamine Research: From Molecular Insights
to Clinical Medicine. New York: Plenum, 2002, pp. 333-336.
Goldstein DS. Cardiac sympathetic denervation in Parkinson’s disease. In
Nagatsu T, Nabashima T, Goldstein DS
(Eds.) Catecholamine Research: From Molecular Insights to Clinical Medicine.
New York: Plenum, 2002, pp. 443-448.
Pacak K, Tjurmina O, Palkovis M, Goldstein DS, Koch CA, Hoff T, Goldsmith P, Chrousos GP. Chronic
hypercortisolemia inhibits dopaminergic activity in the nucleus accumbens. In
McCarty R, Aguilera G, Sabban E, Kvetnansky R (Eds.) Stress. Neural, Endocrine
and Molecular Studies. New York: Taylor & Francis, 2002, pp. 33-36.
Goldstein DS, Elman I, Frank SM, Lenders JWM. Stressor-specific
activation of catecholaminergic systems: Clinical demonstrations. In McCarty R, Aguilera G, Sabban E,
Kvetnansky R (Eds.) Stress. Neural, Endocrine and Molecular Studies. New York:
Taylor & Francis, 2002, pp. 249-253.
Goldstein DS. Sympathetic System Insufficiency/ Dysautonomia. In
Chrousos GP (Ed.) The Adrenal Gland. Endotext.org., Medtext.com, 2002.
Goldstein DS, McEwen B. Commentary: Allostasis, homeostats, and the
nature of stress. Stress 2002; 5:55-58.
Pacak K, Eisenhofer G, Carrasquillo JA, Chen CC, Whatley M, Goldstein DS. Diagnostic localization
of pheochromocytoma: The coming of age of positron emission tomography. Ann N Y
Acad Sci. 2002;970:170-176.
Goldstein DS, Eisenhofer G. Catecholamine synthesis, release, reuptake,
and metabolism. In Izzo J, Black HR (Eds.) Hypertension Primer. Dallas, TX:
American Heart Association, 2003, pp. 5-7.
Goldstein DS. Catecholamines and stress. Endocrine Regul 2003;37:69-80.
Goldstein DS, Eisenhofer G, Kopin IJ. Sources and significance of plasma
levels of catechols and their metabolites in humans. J Pharmacol Exp Ther
2003;305:800-811.
Cuajungco MP, Ando Y, Axelrod FB, Biaggioni I, Goldstein DS, Guttmacher AE,
Gwinn-Hardy K, Hahn MK, Hilz MJ, Jacob G, Jens J, Kennedy WR, Liggett SB, O'Connor
DT, Peltzer SR, Robertson D, Rubin BY, Scudder Q, Smith LJ, Sonenshein GE,
Svejstrup JQ, Xu Y, Slaugenhaupt SA.
Hereditary dysautonomias: Current knowledge and collaborations for the future.
Clin Auton Res 2003;13:180-195.
Goldstein DS. Dysautonomia in Parkinson’s disease: Neurocardiological
abnormalities. The Lancet Neurol 2003;2:669-676.
Eisenhofer G, Goldstein
DS, Kopin IJ, Crout JR. Pheochromocytoma: Rediscovery as a
catecholalmine-metabolizing tumor. Endocr Pathol 2003;14:193-212.
Goldstein DS. Spinal cord stimulation for reflex sympathetic dystrophy.
Ann Neurol 2004;55:5-6.
Goldstein DS, Eisenhofer G, Pacak K. Diagnosis and localization of
pheochromocytoma: Hypertension Grand Rounds. Hypertension 2004;43:1-4.
Goldstein DS. Imaging of the autonomic nervous system: Focus on cardiac
sympathetic innervation. Sem Neurol 2004;23:423-433.
Eisenhofer G,
Goldstein DS. Peripheral dopamine systems. In Robertson D, Low PA, Polinsky
RJ (Eds.) Primer on the Autonomic Nervous System. New York: Academic Press, 2004,
pp. 176-177.
Goldstein DS. Noradrenergic neurotransmission. In Robertson D, Low PA,
Polinsky RJ (Eds.) Primer on the Autonomic Nervous System. New York: Academic
Press, 2004 pp. 44-59.
Eisenhofer G, Kopin IJ, Goldstein
DS, Leaky catecholamines stores: Undue waste or a stress coping mechanism?
In Pacak K, Aguilera G, Sabban E, Kvetnansky R (Eds.) Stress. Neural, Endocrine
and Molecular Studies. Ann NY Acad Sci 2004;1018:224-230.
Goldstein DS. Functional neuroimaging of sympathetic innervation of the
heart. In Pacak K, Aguilera G, Sabban
E, Kvetnansky R (Eds.) Stress. Neural, Endocrine and Molecular Studies. Ann NY
Acad Sci 2004;1018:231-243.
Pacak K, Eisenhofer G, Goldstein
DS. Functional imaging of endocrine tumors: Role
of positron emission tomography. Endocr Rev 2004;25:568-580.
Eisenhofer G, Kopin IJ, Goldstein
DS. Catecholamine metabolism: A contemporary view with implications for
physiology and medicine. Pharmacol Rev 2004;56:331-349.
Eisenhofer G, Bornstein SR, Brouwers FM, Cheung N-KV, Dahia
PL, de Krijger RR, Giordano TJ, Greene LA, Goldstein
DS, Lehnert H, Manger WM, Maris JM, Neumann HPH, Pacak K, Shulkin BL, Smith
DI, Tischler AS, Young WF Jr. Malignant pheochromocytoma: current status and
initiatives for future progress. Endocrine-Related Cancer
2004;11:423-436.
Goldstein DS. Merging of the homeostat theory with the concept of
allostatic load. In Schulkin J (Ed.) Allostasis, Homeostasis, and the Costs of
Physiological Adaptation. New York: Cambridge University Press 2004, pp.
99-112.
Goldstein DS. Case 7-2004: Multiple-system atrophy. N Engl J Med
2004;351:2881-2883.
Goldstein DS. Cardiovascular autonomic dysfunction. In Pfeiffer RF, Bodis-Wollner I
(Eds.) Parkinson’s Disease
and Nonmotor Dysfunction. New York: Humana Press, 2005, pp. 149-157.
Goldstein DS. The autonomic nervous system and disorders of autonomic
cardiovascular regulation. Isr Med Assoc J (in press).
Goldstein DS. Sympathoadrenal imbalance before neurocardiogenic syncope.
In Proceedings, Third International Congress on Heart Disease. Bologna, Italy:
Moduzzi Editore (in press).
Goldstein DS. Cardiac sympathetic neuroimaging. In Proceedings,
Cardiovascular Molecular Imaging, Society for Nuclear Medicine (in press).
Goldstein DS. Complex regional pain syndromes. In Johnson RT, Griffin
JW, McArthur JC (Eds), Current Therapy in Neurological Diseases. New York:
Elsevier. Volume 7 (in press).
Goldstein DS. Sympathetic nervous system. In Fink G (Ed.) Encyclopedia
of Stress. New York: Academic Press (in press).
Kaufmann H, Goldstein
DS. Dysautonomia in Parkinson disease. Handbook of Clinical Neurology (in
press).
Bibliography
(Books, 2000-date):
1.
Goldstein DS.
The Autonomic Nervous System in Health
and Disease, New York: Marcel Dekker, Inc., 2001.
2.
Nagatsu T, Nabashima
T, McCarty R, Goldstein DS (Eds.) Catecholamine Research: From Molecular
Insights to Clinical Medicine. New York: Plenum, 2002.